Defeating Head & Neck Cancer With Precision, Experience, & Reconstruction.

A biopsy is the gold standard diagnostic tool required to confirm oral cancer. It allows the pathologist to analyze tissue cell mutations microscopically and determine the histopathological grade (well-differentiated, moderately-differentiated, or poorly-differentiated squamous cell carcinoma). Scientifically, there is no clinical evidence showing that performing a diagnostic biopsy under correct surgical protocols causes the cancer cells to metastasize or spread. Delaying a biopsy due to fears of spread prevents correct diagnosis, staging, and therapeutic planning.

When large cancer tumors are resected from the tongue, jaw, or cheek, it leaves a significant functional and aesthetic tissue gap. Microvascular free flap reconstruction involves harvesting healthy donor tissue (skin, fat, muscle, or bone) from another body site (like the thigh - ALT flap, leg - Fibula flap, or forearm - Radial forearm flap) along with its blood vessels. The tissue is transferred to the mouth, and its tiny artery and vein are sutured to neck vessels under a surgical microscope to restore immediate blood supply. This preserves functions like speech, swallowing, and facial contour.

Oral cancer staging is based on the TNM system: T (Tumor Size): The size and depth of invasion (DOI) of the primary mouth tumor. N (Node Involvement): Whether cancer cells have spread to the cervical lymph nodes in the neck. M (Metastasis): Whether the tumor has spread to distant organs (like the lungs or liver). Staging is confirmed using clinical evaluation, histopathology, and imaging scans (contrast CT, MRI, or PET-CT). Earlier stages (Stage I & II) have higher cure rates and often require surgery alone, whereas late stages (Stage III & IV) represent larger tumors or nodal spread and require multi-modality treatments (surgery followed by radiotherapy or chemoradiotherapy).

For patients traveling from other districts in West Bengal, Northeast India (Assam, Sikkim, etc.), or neighboring countries like Bangladesh, Nepal, and Bhutan, we coordinate a rapid clinical pipeline. This includes digital pre-evaluation of reports (biopsy/CT) via our Cancer Report Review system, pre-booking of necessary high-resolution imaging, fast-tracking admission diagnostics, coordinating microvascular surgical teams, and helping schedule postoperative review protocols in their home towns to minimize repeated travel.